The global advanced dermatology drug delivery devices market size was US$ 3,569.9 million in 2021. The global advanced dermatology drug delivery devices market size is forecast to reach US$ 8,785.0 million by 2030, growing at a compound annual growth rate (CAGR) of 10.56% during the forecast period from 2022 to 2030.

Dermatology is a specialty of medicine that focuses on diagnosing, treating, and preventing disorders of the hair, nails, skin, mouth, and genitals. It is a surgical as well as a medical specialty. A dermatologist is a medical doctor who specializes in hair, nails, skin, and aesthetic issues. Drug delivery devices are specialized medical devices used to administer therapeutic substances to specific locations. These are formed of diverse materials such as glass, plastic, and polymers and can be either disposable or reusable. Advanced dermatology drug devices are a subset of drug delivery devices that use the skin to deliver medicines, vaccines, and therapeutic agents to specific target locations.

Factors Influencing Market Growth

Among the factors driving the market are the increasing adoption of connected devices, the increasing number of business synergies with pharmaceutical companies, and the growing focus on prescription/medication adherence.
Strict rules and problems with data privacy may slow down the overall market growth.
The growing development of low-cost devices in order to increase sales in price-sensitive industries is forecast to offer a lucrative opportunity for the global market during the forecast period.
Impact Analysis of COVID-19

The COVID-19 pandemic had a negative impact on the global market growth. Some market participants have noticed a modest decrease in sales. Financials, on the other hand, are already on the mend. The earliest phases of the COVID-19 pandemic, which included complete lockdowns across countries and major cities, disrupted the supply chain and impacted sales. For most global markets, the effect timetable encompassed the end of the first quarter and the beginning of the second quarter of 2020. On the other hand, the COVID-19 pandemic has aided in increasing the market growth forecast indirectly by enhancing the growth prospects of connected dermatological drug delivery devices.

Regional Insights

Europe is forecast to have the fastest growth in the market during the projected period. Europe is a market for new device early adopters, and it is likely to remain one of the top markets for advanced dermatology drug delivery devices. Connected devices have become popular in Europe due to the advantages of these devices over traditional methods, such as improved patient care and safety, shorter hospital stays, and faster recovery. Furthermore, the European Union is one of the world's leading innovators in terms of design, features, and technology.

Leading Competitors

The leading prominent companies profiled in the global advanced dermatology drug delivery devices market are:

AptarGroup, Inc.
Bespak
E3D Elcam Drug Delivery Devices
Kindeva Drug Delivery L.P.
Latch Medical, Becton Dickinson and Company
Medicsensors S.L
Midas Pharma GmbH
Credence MedSystems, Inc.
Nemera
Owen Mumford
Portal Instruments, Inc.
LTS Lohmann Therapie-Systeme AG
Vaxxas Inc.
West Pharmaceutical Services, Inc.
Other Prominent Players
Scope of the Report

The global advanced dermatology drug delivery devices market segmentation focuses on Product Type, Sales Channel, End-Users, and Region.

Segmentation based on Product Type

Injectors
Disposable Injectors
Reusable Injectors
Wearable Injectors
Patches
Microarray (MAP) Patches
Microneedle (MNP) Patches
Solid Removable Microneedles
Coated Microneedles
Dissolving Microneedles
Hollow Microneedles
Hydrogel-Forming Microneedles
Needle-less Patches
Airless Dispensers and Bottles
Dermal Pumps
Valves
Other Devices
Segmentation based on End-Users

Hospitals
Dermatology Practices
Home Use
Segmentation based on Sales Channel

B2B Sales
Pharma
Direct
B2C Sales
OTC
Indirect
Segmentation based on Region

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America